Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Acute myeloid leukemia m1
Acute myeloid leukemia m1
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Acute myeloid leukemia m1
Acute Myeloid Leukemia (AML) is the most common type of acute leukemia in adults. AML is a heterogeneous disease which results from genetic alterations in normal hematopoietic stem cells. These alterations induce differentiation arrest and/or excessive proliferation of abnormal leukemic cells or blasts [1]. Recent genomic studies have identified that recurrent somatic mutations in patients with AML blocks differentiation and/or enhance self-renewal by altered transcription factors [2,3]. The genetic or the epigenetic changes acquired by AML cells disrupt the key growth regulatory pathways and changes will make the normal cells to attain certain malignant characteristics which include inappropriate proliferation in the absence of normal growth signals, indefinite self-renewal in a manner analogous to a stem cell, escape from programmed cell death, inhibition of differentiation, aberrant cell cycle checkpoint control and genomic instability [4].
Incidence and Prevalence
AML is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States with an estimated 18,860 new cases and 10,460 deaths anticipated in 2014 (Cancer Facts & Figures 2014). In the Indian scenario, even though there are not many published data in AML incidence and prevalence, it is noted that the median age diagnosis of AML is much lower when compared to the western population. The median age in Indian population is between 41-45 years (Phillip et al, Unpublished data, CMC, Vellore, Dunna, Rajappa et al. 2010, Abraham, Varatharajan et al. 2012)
Etiology
Most cases of AML is sporadic, characterized by acquisition of somatic mutations in hematopoietic progenitors that confer a proliferative ...
... middle of paper ...
...es the anti-leukemic activity of Ara-C [27].
Ribonucleotide Reductase (RR)
De-novo nucleotide biosynthesis pathway is shown to cross talk with Ara-C activation pathway through the enzyme ribonucleotide reductase (RR). dNTPs generated by RR acts as competitive inhibitor against the active metabolite Ara-CTP and prevents them from incorporating into the DNA. Furthermore, high intracellular dNTP pools inhibit dCK activity, thereby reducing Ara-C activation. The RR holoenzyme is a dimeric protein and comprises of large and small subunits, ribonucleotide reductase M1 (RRM1) and ribonucleotide reductase M2 (RRM2). In patients with advanced non small cell lung cancer treated with gemcitabine, a drug that has similar metabolic pathway like Ara-C, low RRM1 mRNA expression levels was associated with significantly longer median survival than those with high levels [28] [29].
Gleevec scientifically known as CGP57148 (imatinib) and formerly known as STI571 is the new member of a class of agents that act by binding using a kinase inhibitor to try to control CML. It acts as a specific kinase inhibitor, which induces complete remission in the population of those with chronic-phase CML. As a result of the treatment there are no immature cells seen in the blood, and the spleen returns to its normal size in a complete hematologic response (CHR). Equally patients using Gleevec see a dramatic reduction of their tumor clone cells, and restores normal regulatory behavior in the leukemic clone. As well as, the occurrence of a marked increase in the proportion of blast cells, this in addition leaves cells undamaged. If no cells with the Philadelphia chromosome are found in the blood or bone marrow, then patients obtain a complete cytogenetic response (CCyR).
Strategy to target cancer stem cells: The identification of CSC is essential for development of better and effective therapeutic strategies. The drugs used in the current therapies and treatments target not only the tumor cells, but also, the norm...
3. Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS. Eric Wickstrom, Ed. Wiley-Liss, Inc., NY, 1991. pp 25-33, 35-51, 125-141.
I have chosen to write about the constellation Cancer (The Crab). I chose Cancer because it is one of only a handful of constellations that I am actually able to identify in the night sky. Cancer is one of the twelve Zodiac constellations; people whose birthdays fall between June 21st and July 22nd have Cancer as their sign. Cancer is the Latin word for crab, and despite the fact that the constellation looks more like a lobster then a crab, it is still referred to as a crab. The constellation is visible from the northern hemisphere from late winter to early spring.
I have elected to transcribe my proposal argument on issues regarding cancer chemoprevention. I selected this topic because reasonably minute devotion has been given to cancer chemoprevention research in ethical writings, particularly in relation to the huge quantity of moral studies in cancer treatment exploration. Cancer chemoprevention trials test the ability and care of medicinal agents in averting cancer before its manifestation. I believe that phase III chemoprevention issues can be less prevalent by simply ensuring enhanced communication and etiquette between researchers and investigators.
“The word 'leukemia' is a very frightening word. In many instances, it's a killer and it's something that you have to deal with in a very serious and determined way if you're going to beat it” - Kareem Abdul-Jabbar. Many people, including tons of children, fight leukemia every day trying to beat this vicious cancer. Without knowing how leukemia is exactly caused, it puts a damper on how to avoid it.
The body is composed of cells. Normally, these cells divide at a composed and calculated manner. If cells die or are destroyed, the body creates more cells through the division of existing cells. However, occasionally, problems with some cells in the body may occur.
The cell cycle is the process by which cells progress and divide. In normal cells, the cell cycle is controlled by a complex series of signaling pathways by which a cell grows, replicates it’s DNA and divides, these are called proto-oncogenes. A proto-oncogene is a normal gene that could become an oncogene due to mutations. This process has mechanisms to ensure that errors are corrected, if they are not, the cells commit suicide (apoptosis). This process is tightly regulated by the genes within a cell’s nucleus. In cancer, as a result of genetic mutations, this process malfunctions, resulting in uncontrolled cell proliferation. Mutations in proto-oncogene or in a tumour suppressor gene allow a cancerous cell to grow and divide without the normal control imposed by the cell cycle. A change in the DNA sequence of the proto-oncogene gives rise to an oncogene, which
Cancer. The word by itself can conjure images of severely ill and frail people attached to IV medications and chemotherapy drugs as they cling to life in a hospital bed. Other illustrations and pictures depict unrecognizable, misshaped organs affected by abnormal cells that grow out of control, spread, and invade other parts of the body. Cancer studies show that close to one-half of all men and one-third of all women in the United States will be diagnosed with cancer during their lives. Today, millions of people are living with cancer or have had cancer. As patients are newly diagnosed with their specific type of cancer, whether it be breast, lung, prostate, skin, or blood cancer, etc., each patient has to consider what will happen with their future health care plan and who will be involved in their long journey from treatment to recovery. Once diagnosed, cancer patients become the focal point and the center of all activity in terms of care but cancer not only physically invades the patient’s body and well-being, it goes beyond the patient and significantly affects the emotional stability and support from from their loved ones and caregivers. Based on the insidious nature of cancer and typically late detection of malignant diseases, family members (either spouses, children, parents, other relatives, and friends) often become the patient's main caregiver. These caregivers, also known as informal caregivers, provide the cancer patient with the majority of the support outside of the medical facility or hospital environment and become the primary person to provide various types of assistance. They provide the physical support with bathing and assisting in activities of daily living, they become emotional ...
The Phase I trial will be discussed here as it pertains to the topic at hand. The typical treatment for cervical cancer if surgery is not a viable option – like if the cancer has spread, then called locally advanced cervical cancer – is chemotherapy and radiation treatment at the same time. This phase I clinical trial is simply looking to add ipilimumab to this regimen, but once the chemo/radiation has been completed (LACC article). Chemo and radiation destroy tumor cells, which causes tumor-associated antigens to be released. Once released, these antigens are exogenous (outside the cell) and will be presented to helper T cells to initiate an immune response.
Cancer has become a very common illness world wide for any age but mostly affecting adults. One can get cancer from different places in the body that is why there are so many people with cancer, because of all the different types. Cancer can affect any gender, female or male, and any age. It varies from ovarian cancer to prostate cancer, skin cancer to lukemia. Cancer has been a problem for many years yet we have not found a cure to treat and prevent cancer. If one is affected by cancer there are treatments to help take away this illness affecting their body. This essay is about a specific type of treatment for cancer, radiation therapy. There are different types of forms of particles for radiation, for example, protons and waves like x-rays and visible light. These types of radiations are grouped on how much energy they contain because it can cause different affects. A low type of energy radiation can be radio waves and heat, also known as non-ionizing radiation. Ionizing radiation has enough energy to break chemical bonds and knock electrons out of atoms, some examples of these are x-rays and ultraviolet light rays from the sun. That is why radiation is a way to treat cancer because of the strong energy it has to destroy a cancer cell, actually any cell in the body. That’s the issue with radiation therapy, is it worth the damage? It can damage any cell, wether it is healthy or cancerous, which can cause a major affect in the body later on. Although it sounds scary there are other types of treatments such as chemotherapy, targeted therapy, immunotherapy, photodynamic therapy, etc. So if radiation therapy does not sound like the best there are always other options but they do not develop the same results for radiation therapy. Rad...
- Acute myelogenous leukemia (AML): Is a cancer of the bone marrow and the blood that will progress quickly without treatment. This type of leukemia affects mainly the cells that aren’t fully developed. Therefore, making the cells not carry out their normal functions. With this type of dysfunctional activity in the cells at an early stage, this why it is very important to get care and treatment as soon as possible.
...l risk factors that are fully linked developing multiple myeloma. Therefore, preventative measures remain unknown.
Kanwar, V.S. (2013, Sep 16). Diseases & Conditions - Medscape Reference. Pediatric Acute Lymphoblastic Leukemia. Retrieved January 13, 2014, from http://emedicine.medscape.com/article/990113-overview#a0156
Bone cancer is classified into primary bone cancer & secondary bone cancer. Basically, Primary bone cancer starts in the bone; then the cancer initially forms in the cells of the bone; while the secondary cancer starts elsewhere in the body and gets spread to the bone.